10.1021/acs.jmedchem.5b01198 240
Common sense, yesbut critical for long-term success
Unlike most peptides, it targets sleep quality, cellular renewal, and longevity through a mechanism tied to the pineal gland
GHK-Cu tackles these issues on several fronts
The STEP 1 trial, which is the largest clinical study on semaglutide 2.4 mg for weight management, followed nearly 2,000 adults over 68 weeks and documented these outcomes in detail
Common side effects (affecting up to 1 in 10 people): Vomiting Constipation Abdominal pain or discomfort Dyspepsia (indigestion) Decreased appetite Hypoglycaemia (low blood sugar), particularly when used in combination with insulin or sulphonylureas Injection site reactions (redness, itching, or bruising) Less common but important side effects: Acute pancreatitis: Characterised by severe, persistent abdominal pain that may radiate to the back